Evidence-based guideline for neonatal pain management in China (2023).
10.7499/j.issn.1008-8830.2210052
- Collective Name:National Clinical Research Center for Child Health and Diseases/Ministry of Education Key Laboratory of Child Development and Disorders/Chongqing Key Laboratory of Pediatrics/Children's Hospital of Chongqing Medical University
- Publication Type:Journal Article
- Keywords:
Clinical practice guideline;
Neonate;
Pain
- MeSH:
Child;
Infant, Newborn;
Humans;
Pain Management;
Pain;
China;
Child Health;
Consensus
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(2):109-127
- CountryChina
- Language:Chinese
-
Abstract:
Pain disrupts neonatal vital signs and internal environment homeostasis and affects the recovery process, and recurrent pain stimulation is one of the important risk factors for neurodevelopmental disorders and some chronic diseases. In order to standardize pain management practice in neonatal wards in China and effectively prevent and reduce the adverse effects of pain on the physical and mental development of neonates, National Clinical Research Center for Child Health and Diseases (Children's Hospital of Chongqing Medical University) convened a multidisciplinary panel to formulate the evidence-based guideline for neonatal pain management in China (2023 edition) following the principles and methods for the guideline development issued by the World Health Organization. Based on the best evidence and expert consensus, this guideline gives 26 recommendations for nine clinical issues, i.e., the classification and definition of neonatal pain, common sources of pain, pain assessment principles, pain assessment methods, analgesic principle, non-pharmaceutical analgesic methods, pharmaceutical analgesic methods, parental participation in pain management, and recording methods for pain management, so as to provide medical staff with guidance and a decision-making basis for neonatal pain assessment and analgesia management.
